CLINICAL_TRIALS
trial_result
· 2020-11-19
Clinical Trial Update: Sildenafil Treatment for Mild TBI [Phase 2]
Summary
Phase 2 trial update on sildenafil for mild traumatic brain injury has been terminated; results posted previously.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Vascular System Injuries, Concussion, Brain | Phase 2 | Status: TERMINATED | Results posted: 2020-11-19